FTC Rips Wyeth, Teva Arguments In Effexor Antitrust Suit
The Federal Trade Commission on Friday said Wyeth LLC and Teva Pharmaceuticals USA Inc.'s characterization of an authorized generic deal violates antitrust law, as the companies try to escape New Jersey...To view the full article, register now.
Already a subscriber? Click here to view full article